Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03313284
Other study ID # REHYPE_2017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 29, 2017
Est. completion date July 4, 2018

Study information

Verified date August 2018
Source Swiss Federal Institute of Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The prevalence of pre-hypertension and hypertension in the elderly is very high. Apart from medication, physical exercise training is a potential strategy to reduce blood pressure, however, the ability to perform exercise can be limited in the elderly. Hence, alternative non-pharmacological strategies to reduce blood pressure are necessary. Two interventions that have been shown to positively influence blood pressure are respiratory muscle training (RMT) and intermittent hypoxia (IH). Whether a combination of RMT and IH yields even better effects is currently unknown. Therefore, in this study, the effect of a single session of RMT with and without IH on blood pressure and associated cardiovascular parameters will be investigated in elderly subjects with pre-hypertension.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date July 4, 2018
Est. primary completion date July 4, 2018
Accepts healthy volunteers No
Gender All
Age group 65 Years to 80 Years
Eligibility Inclusion Criteria:

- Age: 65-80 years

- Systolic blood pressure between 130-139 mmHg and diastolic blood pressure lower than 90 mmHg

- Non smoking

- Normal Body-Mass-Index (BMI): 18.5-24.9 kg·m-2

- Normal Lung Function

- Willing to adhere to the general study rules

Exclusion Criteria:

- Known or suspected non-compliance, drug or alcohol abuse

- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant

- Previous enrolment into the current study

- Enrolment of the investigator, his/her family members, employees and other dependent persons

- Intake of blood pressure medication

- Intake of medications affecting sleep or the performance or the respiratory, cardiovascular or neuromuscular system

- Acute or chronic illness other than prehypertension

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
RMT
RMT consists of six bouts of 5-min of volitional hyperpnoea . After each RMT bout, participants will breathe room air for 5 minutes.
RMT + IH
RMT and IH consist of six bouts of 5-min of volitional hyperpnoea. After each RMT bout, participants will breathe a hypoxic gas mixture (10.5% O2 ) for 5 minutes.
Control
No intervention

Locations

Country Name City State
Switzerland Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
Swiss Federal Institute of Technology

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in blood pressure in mmHg Blood pressure before, during, and after each intervention measured with an automated sphygmomanometer At baseline after 20 min of lying in a supine position, every 5 minutes during the 60 min intervention, and 20, 35 and 50 min after the end of the intervention
Secondary Change in pulse wave velocity in m/s Carotid-femoral pulse wave velocity before and after each intervention, assessed with a device that simultaneously records (non-invasively) pressure signals from the carotid and femoral arteries At baseline after 25 min of lying in a supine position, and 25, 40 and 55 min after the end of the intervention
Secondary Change in cardiac output in L/min Cardiac output before, during, and after each intervention measured with impedance cardiography At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention
Secondary Change in total peripheral resistance in dyn x s/cm^5 Total peripheral resistance before, during, and after each intervention measured with impedance cardiography At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention
Secondary Changes in baroreflex sensitivity in ms/mmHg Baroreflex sensitivity before and after each intervention assessed with photo plethysmography At baseline after 15min of lying in a supine position, and 15, 30 and 45 min after the end of the intervention
Secondary Change in heart rate variability in ms Heart rate variability measured before, during and after each intervention with impedance cardiography At baseline after 15min of lying in a supine position, every 5 minutes during the 60 min intervention, and 15, 30 and 45 min after the end of the intervention
Secondary Change in peripheral oxygenation during sleep in %Saturation Peripheral oxygenation during sleep measured at home after each intervention with a finger pulse oxymeter Continuously during the night following each intervention, from time to bed until wake up time in the morning (i.e. on average approximately 8hours)
Secondary Change in sleep efficiency defined as the ratio of total sleep time and time in bed Sleep efficiency measured at home after each intervention with an actigraph Continuously during the night following each intervention, from time to bed until wake up time in the morning (i.e. on average approximately 8hours)
Secondary Change in subjective sleep quality Sleep quality (i.e. "How well did you sleep?" and "How recovered are you?") measured at home after each intervention with a visual analog scale (VAS). The two VAS consists each of a 10cm-horizontal line, with the left end of the lines representing low sleep quality ("slept very badly" and "not recovered at all", respectively) and the right end representing good sleep quality ("slept very well" and "completely recovered", respectively). Participants are asked to draw a vertical line in between the two ends on each of the two VAS. Within 5 minutes after waking-up following the night after each intervention
See also
  Status Clinical Trial Phase
Completed NCT01741779 - Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function N/A
Withdrawn NCT01074918 - Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients Phase 1/Phase 2
Completed NCT00288158 - Primary Prevention of Hypertension in Obese Adolescents Phase 2
Completed NCT01190319 - Study: Effects of Strawberries on Blood Pressure N/A
Completed NCT01008176 - Restoring Sleep Homeostasis to Lower Blood Pressure N/A
Unknown status NCT02197910 - Different Dosages of Bioactive Wheat Peptides and Blood Pressure Level and CVD Risk Biomarkers in Healthy Subjects N/A
Recruiting NCT04543656 - Personalized Blood Pressure Care Using IoMTs and Artificial Intelligence N/A
Completed NCT03168789 - Tension Tamer Randomized Control Trial N/A
Completed NCT00553969 - Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease Phase 1/Phase 2
Completed NCT00170937 - A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome Phase 4
Completed NCT01741766 - The Effects of Stretching Training on Arterial Function and Autonomic Control N/A
Completed NCT02143817 - Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition N/A
Terminated NCT00388388 - Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects Phase 2
Completed NCT02148458 - Short Term Intermittent Fasting and Mediterranean Diet N/A
Terminated NCT01349114 - Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects Phase 4
Completed NCT02038179 - Center of Research Translation (CORT) Project 2 Phase 2/Phase 3
Completed NCT01202175 - Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension Phase 4
Completed NCT00970931 - Hypertension Prevention in Pre-Hypertensive Individuals Phase 3
Completed NCT01841840 - The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke N/A
Not yet recruiting NCT01364675 - Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects N/A